Xinqiao Hospital Of Chongqing

This early-stage trial tested a new treatment for people with HPV16-positive head and neck or cervical cancer that had spread or come back. The therapy uses a patient's own immune cells, specially trained to recognize and attack HPV-infected cancer cells. Some of these cells were…

This early-phase study tested a new type of cell therapy (CAR-T cells) designed to attack tumors that have a protein called ALPP. Five adults with advanced solid tumors that had no standard treatment options received the therapy. The main goals were to check safety and see if the…

This trial tested a new treatment for people with a type of head and neck cancer linked to the Epstein-Barr virus (EBV). The treatment uses specially engineered immune cells (TCR-T cells) that can recognize and attack cancer cells, plus they release a substance to block a common …

This early-stage trial tested a new treatment for a type of throat cancer linked to the Epstein-Barr virus. Researchers took patients' own immune cells, engineered them to recognize and attack the virus-infected cancer cells, and also added a feature to boost their cancer-killing…

This early-stage study tested a new treatment called Anti-ALPP CAR-T cells in 5 people with advanced solid tumors that had not responded to standard therapies. The treatment uses a patient's own immune cells, modified to attack a protein (ALPP) found on certain cancer cells. The …